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Abstract: In recent years much attention has been paid to the biosynthesis of silver nanoparticles (AgNPs) and their important medical
applications. The current study employs Fusarium oxysporum for the formation of silver nanoparticles and examines the antimicrobial
activity of the particles against some multidrug-resistant (MDR) microbes. Silver nitrate was transformed into silver oxide, forming
well-dispersed nanoparticles, by the action of F. oxysporum metabolically. The size of the nanoparticles ranged from 21.3 to 37.3 nm,
and UV-spectroscopy showed a peak at 408–411 nm. Moreover, SEM, TEM, and AFM results revealed spherical and oval shapes and
showed no sign of aggregation. Furthermore, the FT-IR histogram detected amide I and amide II, which are responsible for the stability
of AgNPs in the aqueous solution. The AgNPs halted the growth of MDR bacteria, including some members of Enterobacteriaceae and
Staphylococcus species at a concentration of 50% (v/v). The AgNPs also have the ability to inhibit pathogenic yeasts Candida albicans and
Candida krusei. The AgNPs displayed antigrowth activity against MDR microbes, suggesting that they might be potential alternatives
to antibiotics. However, additional studies may be necessary to substantiate the fact that the benefits of using nanoparticles outweigh
the potential risks.
Key words: Fusarium species, nanotechnology, silver nanoparticles, medical applications

1. Introduction
Nanotechnology is relatively a new science of study in which
a set of sciences, including the STEM (science, technology,
engineering, and mathematics) disciplines, are involved
to synthesize nanomaterials of about 1–100 nm. At the
nanoscale level, materials have distinct chemical, physical,
optical, magnetic, and electrical properties due to their
large surface area to volume ratio (Chaturvedi et al., 2012).
One of the most important aspects of nanotechnology
is the synthesis of nanoparticles (NPs), which form the
essence of nanomaterials (Ishida et al., 2014). NPs exhibit
new properties based on specific characteristics such as
size, distribution, and morphology. Today NPs are used
in many fields, including manufacturing and materials,
environmental sciences, energy and electronics, and
medicine. Multidrug-resistant (MDR) microbes are a
growing problem in the treatment of infectious diseases
due to the widespread use of broad-spectrum antibiotics,
which has resulted in the production of antibiotic
resistance for many human bacterial pathogens (Franci et
al., 2015). Advances in nanotechnology have opened new
horizons in nanomedicine, allowing the synthesis of NPs,
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54

which are now considered a viable alternative to antibiotics
and seem to have high potential in solving the problem of
the emergence of microbial multidrug resistance (Rai et
al., 2012).
During the last decade, increased interest has been
paid to biological systems for the synthesis of NPs
compared with other methods, i.e. physical and chemical
methods. The latter approaches are expensive and have
many limitations; therefore, scientists are developing
clean, economical, and ecofriendly biological approaches
as an alternative for NP synthesis (Rai et al., 2009; Seshadri
et al., 2011; Wei et al., 2012). Microorganisms (mainly
bacteria, yeasts, and molds) have efficiently proven their
ability to absorb and accumulate inorganic metallic ions
from the surrounding environment. More importantly, the
ability of a biological entity to use its inherent biochemical
processes to transform inorganic metallic ions into metal
NPs has led to a relatively new and largely unexplored
field of research. Among microbes, filamentous fungi
are widely used as biocatalysts in NP preparation
(Mukherjee et al., 2002; Sawle et al., 2008). In addition to
heavy metal tolerance, fungi have the ability to produce
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higher amounts of proteins, leading to higher rates of NP
synthesis (Mohanpuria et al., 2008). Several papers have
been published describing the synthesis of silver NPs
using mycosynthesis (Ahmad et al., 2003; Mishra et al.,
2011; Soni et al., 2012; Gopinath et al., 2015); however,
there is a continuing effort throughout the world to exploit
fungal species in the nanotechnology field. A few reports
have been published about nonpathogenic filamentous
fungus Fusarium species and their capabilities in reducing
aqueous silver ions extracellularly to generate silver NPs
(Durán et al., 2005; Ahmad et al., 2010). However, these
previous studies did not cover the broad spectrum of silver
NPs synthesized by the action of F. oxysporum against
pathogenic bacteria and pathogenic yeasts.
In this study, the tested hypothesis is that a local
isolate of filamentous fungus F. oxysporum tolerates heavy
metals and actively synthesizes silver NPs extracellularly.
Therefore, the main objectives of the present study were
using F. oxysporum as a biocatalyst for the synthesis of NPs
and investigation of their antimicrobial activity against
some MDR isolates.
2. Materials and methods
2.1. Synthesis of AgNPs
A local isolate of F. oxysporum (F2A) was used for the
synthesis of silver nanoparticles (AgNPs). Colonies of F.
oxysporum were grown on potato dextrose agar (PDA)
plates for 6 days at 28 °C and were used to inoculate 250
mL of MYPG medium (consisting of 3 g malt extract, 3
g yeast extract, 2 g peptone, and 10 g glucose per liter)
in Erlenmeyer flasks. The flasks were incubated at 28 °C
for 7 days with shaking at 150 rpm. Mycelial pads were
harvested aseptically and washed 3 times with distilled
water. The biomass of fungi was weighed and then used
for the synthesis of nanoparticles applying an approach
similar to that of Ahmad et al. (2003) and Durán et al.
(2005) with some modifications. Briefly, three Erlenmeyer
flasks were prepared; the first one contained 10 g of wet
biomass and 100 mL of sterile distilled water and this flask
was used as a negative control. The second flask included
10 g of mycelium pad and 100 mL of 1 mM silver nitrate
(the metal solution was sterilized with a 0.22-µm Millipore
filter). The third flask was also used as a negative control
since it contained 100 mL of metal solution only. All flasks
were incubated at 28 °C in the dark for 190 h with shaking
at 150 rpm. Filtration and then centrifugation (at 5000 rpm
for 20 min) were carried out, and then the supernatants
were characterized.
2.2. Characterization of AgNPs
The synthesized NPs were characterized based on
specific surface plasmon resonance peak, shape, size,
and interaction between protein and NPs. To confirm
the synthesis of AgNPs, 2 mL of sample was measured

spectrophotometrically at a wavelength ranging from
300–600 using a Genesys 6 spectrophotometer (Thermo
Electron, USA). Considering that the primary goal of
this study was to produce a powerful antimicrobial
nanomaterial, the agar well diffusion method was
conducted to learn the antimicrobial properties of the
NPs. Briefly, pathogenic bacterial isolates (Escherichia coli,
Staphylococcus epidermidis, and Staphylococcus aureus)
were grown in nutrient broth for 24 h at 37 °C. The
number of cells per milliliter was adjusted to be 108 in a
plate count procedure; 100 µL of inoculum (1 × 108 cells/
mL) was swabbed onto Mueller Hinton agar plates. Wells
were made using gel puncture and then 0.1 mL of different
dilutions of AgNPs (10%, 25%, 50%, 75%, and 100%)
was loaded into certain wells. The plates were incubated
at 37 °C overnight and then the zone of inhibition was
measured (mm). This experiment was performed three
times and then averages and standard deviations were
calculated using Microsoft Excel. In accordance with
the collected results of the agar well diffusion method,
the NPs were subjected to microscopic identification via
SEM (CamScan 3200LV, UK) and TEM (Philips CM10,
the Netherlands) (procedure modified from Gurunathan
et al., 2009). To confirm the formation of AgNPs, atomic
force microscopy (AFM; Phywe measure Nano, UK) was
used. To identify the presence of possible biomolecules,
Fourier transmission infrared spectroscopy (FT-IR; WQF520 Biotech, UK) was applied.
2.3. Antimicrobial activity of AgNPs
All pathogenic microbes obtained from Sulaimani
Teaching Hospitals in Kurdistan Region, Iraq, were MDR.
The activity of AgNPs was tested against pathogenic
microbes using growth inhibition by using microtiter plate.
Growth inhibition assays were performed on Escherichia
coli, Enterobacter cloacae, Klebsiella pneumoniae, Proteus
mirabilis, Pseudomonas aeruginosa, Staphylococcus aureus,
and Staphylococcus epidermidis. Fresh overnight cultures
of pathogenic bacterial isolates were adjusted to be 108
cells/mL as mentioned previously. A bacterial culture of
120 µL was placed in 96-well microtiter plates and then
80 µL of an appropriate dilution of AgNPs (25%, 50%,
75%, and 100%) was added. Nutrient broth (200 µL) was
used as a negative control and 120 µL of bacterial culture
mixed with 80 µL of fungal extract was also applied as a
negative control. The microtiter plates were incubated at
37 °C for 18 h (modified procedure of Salem et al., 2015).
The optical density (OD) at 600 nm was measured using
a microplate spectrophotometer (Biotech μQuant, USA).
From each well, 5 µL was taken and spotted onto nutrient
agar plates, and then all plates were incubated at 37 °C
for 18 h. Growth percentage was calculated based on the
average and standard deviation of triplicate results. For
pathogenic fungi (Candida albicans and Candida krusei),

55

AHMED et al. / Turk J Biol
the same method as mentioned above was used, except
that the medium was replaced with potato dextrose broth
and PDA. The number of cells per milliliter was adjusted
to be 106 using a hemocytometer.
3. Results
3.1. Synthesis and characterization of AgNPs
F2A was able to convert AgNO3 into AgNPs after 190 h of
incubation as noticed visually by color change from white
to light brown, whereas the control vessels developed
no change in their original color (Figure 1; inset). The
wavelength scan of UV-Vis spectra revealed a broad peak
between 408 and 411 nm, indicating the surface plasmon
resonance nature of the AgNPs that is present in the brown
supernatant (Figure 1).
Interestingly, the colored solution of AgNPs displayed
a powerful inhibition against the clinical isolates (Figure
2). Bacterial growth was inhibited even at the lowest
concentration. From the average values of inhibition
zones (Figure 2, insets), the highest antimicrobial activity
was observed against S. epidermidis, which was 14 mm in
diameter, whereas the cultures of S. aureus and E. coli also
showed clear zones of inhibition, which were about 13 and
12.25 mm in diameter, respectively. Moderate antibacterial
activity was noticed at a lower concentration of AgNPs
(25%), while it was weak in 10% AgNPs against the tested
bacteria.
SEM was used to determine the presence and size
of AgNPs. After drying, the thin layer of AgNPs was
analyzed. The scanning electron micrograph showed the
presence of high-density AgNPs with mainly spherical
shape (Figure 3A, white arrows). The data obtained from
TEM micrographs show that the synthesized AgNPs have
a spherical shape and the size ranged from 21.3 to 37.3 nm,
uniformly distributed without significant agglomeration
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Figure 1. UV-Visible absorption spectra of AgNPs: a) AgNO3
solution (1 mM) control; b) biomass of F2A test sample before
incubation, c) supernatant of (F2A) control, d) biomass of (F2A)
test sample. Inset: Color change of filtrate from white (b) to light
brown (treated) after synthesis of AgNPs (d).
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(Figure 3B, black arrows). A two-dimensional horizontal
cross-section of the AgNPs by AFM indicated that the
surface topography of the synthesized silver nanoparticles
was almost spherical in shape (Figure 3C). Histogram
analysis revealed that the mean particle size was
approximately 21.5 nm.
The absorption peaks of AgNPs (Figure 4) are located
at 538, 679, 768, 847, 1070, 1340, 1432, 1516, 1630, 2943,
and 3411 cm–1 in the region of 500–400 cm–1. The band at
1630 cm–1 is assigned to the stretching vibration of -C=O
(carbonyl), identified as the amide I band, whereas the
bands at 3411 cm–1 and 1516 cm–1 represent stretching and
bending vibrations of -NH, respectively.
3.2. Antimicrobial activity of AgNPs
The effectiveness of AgNPs on MDR clinical isolates was
determined by comparing growth rates under control
and test conditions (Figures 5–7). AgNPs showed
antimicrobial properties against all tested microbes;
however, their exact effect on microbes was not clearly
understood and was not investigated in this study. As
seen in Figure 5, at a concentration of 25% (v/v) AgNPs,
Enterobacter cloacae, E. coli, Pseudomonas aeruginosa,
and Klebsiella pneumoniae were inhibited significantly,
whereas 25% AgNP concentration showed no significant
effect on Proteus mirabilis. In addition, similar behavior
was exhibited at 25% and 50% concentrations against both
Pseudomonas aeruginosa and Klebsiella pneumoniae.
All gram-negative bacteria used here were inhibited
significantly; the highest antimicrobial activity was
observed against E. coli and Proteus mirabilis, whose
growths were restrained at the AgNP concentration of
50%. On the other hand, at a relatively high concentration
(75%) of AgNPs, the growth of the other isolates was
suppressed. In Figure 6, two gram-positive bacteria are
shown. The concentration of AgNPs also halted the growth
of these bacteria. It seems that S. epidermidis tolerates up
to about 50% of AgNPs in comparison with S. aureus.
In Figure 7, the fungicidal effect is observed at a
concentration of 50% (v/v) against Candida albicans while
Candida krusei showed a high degree of resistance.
4. Discussion
Many questions remain unanswered about the resistance
mechanisms of fungal strains towards many inhibitors
such as heavy metals. Although fungi possess many
properties that influence metal toxicity, the mechanisms
involved in metal tolerance are highly dependent on the
metabolic and nutritional status of the organism (Salem
et al., 2015). In this study, silver nitrate has halted the
growth of 7 species of Fusarium except the F2A isolate
(data not shown); F2A survived the effects of 1 mM silver.
F2A might develop a new survival strategy as an adaptive
response to unfavorable environmental conditions.
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Figure 2. Inhibition zone assay of clinical isolates by synthesized AgNPs. Inset: A) S. epidermidis; B) S. aureus; C) E. coli.
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Figure 3. Micrograph of AgNPs synthesized by F2A: A) SEM image, B) TEM image, C) AFM image. Left upper picture
depicts the 3D image of the AgNPs whereas left lower picture represents the 2D image of the AgNP horizontal cross-section.
Right image indicates the histogram analysis, showing average particle size of 21.5 nm.

Consequently, F2A was selected as a biocatalyst for the
synthesis of AgNPs. F2A was able to reduce silver ions to
silver NPs since it is well known that AgNPs in aqueous
solutions show a yellowish brown color (Ahmad et al.,

2003). This bioreduction occurred through catalysis by
the reducing agent secreted from the F2A biomass into
the solution. Fusarium species have been used previously
for NP production (Ahmad et al., 2003; Durán et al., 2005;
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Figure 4. FT-IR spectrum of silver nanoparticles synthesized by F2A. Gray boxes depict both amide I (-C=O) and amide
II (-NH) bands.
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Figure 5. Growth inhibition assay using microtiter plate technique. Inset: 5 µL was taken from each well
and spotted onto nutrient agar plates. A) E. coli; B) Enterobacter cloacae; C) Klebsiella pneumoniae; D)
Proteus mirabilis; E) Pseudomonas aeruginosa.

Gadd, 2007); however, previous studies did not cover
the broad spectrum of silver NPs synthesized by the
action of F. oxysporum against pathogenic bacteria and
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pathogenic fungi. The slow silver reduction (~190 h) could
be the result of unfavorable growth conditions, due to the
presence of relatively high concentrations of silver nitrate.
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Figure 6. Growth inhibition assay using microtiter plate. Inset:
5 µL was taken from each well and spotted onto nutrient agar
plates. A) S. epidermidis; B). S. aureus.

Figure 7. Growth inhibition assay using microtiter plate. Inset:
5 µL was taken from each well and spotted onto PDA plates. A)
Candida albicans; B) Candida krusei.

The formation of silver NPs might occur by the action of
reductase enzyme(s) excreted during fungal growth phases
(Durán et al., 2005). However, the restricted growth rate
of the fungus in such batch cultures may perhaps lead
to the delayed excretion of the enzyme(s), which leads
to the slow reduction of silver nitrate. Notably, this long
period of time gives stable AgNPs, as mentioned below.
Thereafter, the colored solution was tested and analyzed
spectrophotometrically using UV-Vis in the scan range
of 300–600 nm (Figure 1). Interestingly, AgNPs absorbed
light at different wavelengths and were excited due to charge
density at the interface between conductor and insulator
to give a respective peak on UV-Vis spectrophotometry
(Gurunathan et al., 2015), which is in agreement with
several other studies (Rodríguez-León et al., 2013; Kumar
et al., 2016). These results suggest that the biopolymer
protein plays a key role in providing stability to AgNPs.
The biopolymer forms a ligand-shell surrounding AgNPs
at the core, forming a silver polymer core-shell structure.
The polymeric shell decreases the surface potential that is
responsible for accumulation of the silver nanoparticles to
larger aggregates (Busi et al., 2014).
Frequently, microbes are considered dead when
they cannot be cultured. However, variation in the size
of inhibition zones depends upon a number of factors
such as the type of pathogens, synthesis method, and
concentrations of AgNPs. It was observed in this study
that increasing the concentration (v/v) of AgNPs in wells
led to consistently increasing zones of inhibition (Figure
2). At 40 mg/mL, AgNPs showed a good inhibitory zone
against various pathogenic bacteria (Gopinath et al., 2015;
Sanyasi et al., 2016). Gopinath et al. (2015) showed that
the shapes of AgNPs synthesized by F. oxysporum were

spherical to oval in shape with little aggregation. The SEM
micrographs of silver NPs show aggregated particles due
to the capping agent(s), mainly metabolites of the action
of microbes (Figure 3A). Therefore, the particle sizes
measured by SEM can be larger than the sizes measured
by TEM or XRD (Durán et al., 2005). TEM images have
provided evidence of extracellular synthesis of AgNPs
(Kowalczyk et al., 2011). TEM is widely used to analyze
the structure and size of NPs and in this study it was used
to determine the size and shape of silver NPs (Figure 3B).
Basavaraja et al. (2008) synthesized AgNPs ranging from
8 to 60 nm with polydispersity and mostly spherical in
shape. Ahmad et al. (2003) obtained AgNPs with a size of
5–50 nm with a spherical shape. Together, SEM and TEM
analysis provide further insight into the morphology and
particle size distribution profile of the AgNPs synthesized
by F. oxysporum. Besides SEM and TEM techniques, AFM
was used to obtain information about the effect of solution
chemistry on the AgNPs’ dissolution kinetics. In this
case, aggregation cannot occur because the particles are
immobilized. AFM is an obvious choice for characterizing
dissolutive changes in the size and shape of AgNPs since
it can resolve sample topography with subnanometer
precision. The three-dimensional images showed the
average roughness and inhomogeneity of the cluster
formation of AgNPs (Figure 3C). On the other hand, Majeed
et al. (2016) showed that AgNPs were spherical and 30–50
nm in size. FT-IR measurement was performed to identify
the possible biomolecules responsible for the capping
and efficient stabilization of the metal nanoparticles and
to understand the protein/metal NP interaction. The FTIR spectroscopic analysis clearly reveals that proteins are
responsible for the reduction and stabilization of AgNPs
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(Figure 4). Many studies have proved that bands at 1516
cm–1 in addition to C=O (carbonyl) stretching and –N–H–
stretching vibrations correspond to the amide linkages of
proteins (Hamedi et al., 2014; Luna et al., 2016). Hamedi
et al. (2014) showed that the appearance of peaks in the
amide I and amide II regions describes proteins and/or
enzymes that have been found to be responsible for the
reduction of metal ions when using microorganisms as
biocatalysts. It seems that the F2A metabolites play dual
functions in the formation and stabilization of AgNPs.
In the 1940s, western industries began to focus on
the production of fungal-specific secondary metabolites
by the cultivation of the fungi on relatively raw materials
using submerged and solid state cultures. Since then,
tremendous medically significant metabolites (such as
antibiotics) are being produced, purified, and sold for
medicinal purposes. Antibacterial activities of AgNPs in
this report have been investigated against MDR grampositive and gram-negative bacteria (Figures 5 and 6).
This resistance might be attributed to the presence of a
self-produced extracellular matrix in both isolates and
its roles in the defense mechanisms (Jagnow et al., 2003;
Periasamy et al., 2015). Moreover, cells may be inactive or
damaged and therefore unable to reproduce temporarily.
With time and appropriate conditions, the cells may
recover and begin to reproduce. The presence of multiple
mechanisms to avoid inhibitors in some clinical strains
allow them to survive and resist the most commonly used
drugs. This tolerance could be due to specific antibiotic
resistance genes and the formation of biofilms (Otto, 2009).
Although the inhibition of bacterial growth indicates that
AgNPs possess a bactericidal property, the mechanisms
that contribute to cell death remain vague. One hypothesis
is that AgNPs are involved in the disruption of the
membrane with a generation of reactive oxygen species
and ultimately lead to the death of pathogens (Prabhu and
Poulose, 2012). Another possibility is that AgNPs have
the ability to adhere to the bacterial cell wall and produce
cracks and pits, through which the internal cell contents are
released (Feng et al., 2000). The efficacy of AgNPs against
pathogenic yeasts was evaluated by identifying growth

percentage in a 96-well microtiter plate. More importantly,
the AgNPs produced by F. oxysporum exhibited potent
antifungal activity against two species of Candida (Figure
7). Although Candida krusei is an uncommon clinical
isolate, it does tolerate a broad array of antifungals (Pfaller
et al., 2008). Therefore, finding a robust agent is necessary
for many opportunistic pathogens like Candida krusei.
A previous study showed that AgNPs biosynthesized by
the fungus Arthroderma fulvum showed considerable
antifungal activity against Candida species (Xue et al.,
2016). Lara et al. (2015) found that AgNPs caused severe
morphological changes in fungal cells manifested by
disruption of the cell membrane structure.
In conclusion, the AgNPs synthesized by F. oxysporum
were characterized as spherical to oval in shape with
average size ranging between 21.5 and 37.3 nm. The AgNPs
remained stable with a slight change in color. However, the
peak of surface plasmon resonance remained unchanged
with the same region after storage for 4 months under
4 °C cooling conditions (data not shown). Obviously,
pathogenic bacteria continue to develop resistance to a
long list of antibiotics, leading to untreatable infections.
AgNP-producing F2A shows promise as an effective
biocatalyst and its Ag nanoparticles have powerful lethality
against MDR microbes. AgNPs showed inhibitory effects
against all MDR bacteria used in this study. AgNPs also
displayed antifungal activity against pathogenic yeasts. For
future work, the toxicity of AgNPs needs to be studied to
establish that the benefits of using nanoparticles outweigh
the potential risks.
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